Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of SONN will rise by +56.16% over the next 2 Weeks and hit $1.97 by Tuesday, December 16, 2025. In that time frame, SONN's share price is expected to range between $1.28 and $2.71.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Dec 16, 2025 | 2.46 | 3.51 | 4.42 |
| Dec 15, 2025 | 3.34 | 4.26 | 5.26 |
| Dec 12, 2025 | 3.43 | 4.41 | 5.43 |
| Dec 11, 2025 | 3.23 | 4.20 | 5.22 |
| Dec 10, 2025 | 3.09 | 4.07 | 5.06 |
| Dec 9, 2025 | 2.58 | 3.56 | 4.56 |
| Dec 8, 2025 | 3.23 | 4.31 | 5.31 |
| Dec 5, 2025 | 3.44 | 4.46 | 5.37 |
| Dec 4, 2025 | 3.26 | 4.25 | 5.21 |
| Dec 3, 2025 | 3.14 | 4.12 | 5.08 |
SONN shares fell -59.35% in Tuesday, December 2, 2025's trading session, dropping from a previous close of $3.10 to move at $1.26. The stock demonstrated notable intraday movement (see SONN's key stats for a full breakdown), fluctuating between $1.26 and $3.23, a +156.35% trading range. While recent weeks have seen some volatility, SONN has managed to secure a -74.23% drop over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 8.64M shares changing hands, 7.74M more than the previous session. This amounted to $10.88M in total market activity.
Will SONN Continue Its Upward Trend?
According to analyst ratings and projections for SONN, Sonnet BioTherapeutics Holdings, Inc. shares are anticipated to increase by +71.49%, potentially reaching $4.42 per share by December 16, 2025. Short-term technical indicators currently suggest a bullish sentiment for SONN. However, the stock has recorded 18 negative trading days within the past 30 sessions. Based on the SONN stock forecast, now is a good time to buy SONN stock because its current trading price is -64.12% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on SONN covering social and institutional perspectives.
SONN Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into SONN's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 19.81% to 33.67%) suggest the stock is experiencing strong bearish momentum. The 50-day RSI, at 43.00%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 45.47%, maintains a neutral outlook for the long term. Insights into SONN's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Sonnet BioTherapeutics Short-Term Forecasts
SONN Forecast For Next 5 Days
Our algorithm anticipates Sonnet BioTherapeutics (SONN) stock could hit $2.74 by Jan 01, 2026. This represents a +117.20% fall from today's price, following a -74.02% change over the past five days.
SONN Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Sonnet BioTherapeutics Holdings, Inc. (SONN) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $3.07, which would mean a +143.65% increase from the current price of $1.26. Projections for this period range from a high of $4.19 to a low of $1.80.
SONN Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Sonnet BioTherapeutics's price over the next three months point to a drop. SONN stock is expected to peak at $4.90 on Mar 09, 2026 before potentially dipping to $0.00 on May 26, 2026. On average, SONN is likely to trade around $0.31 in the coming 90 days.
Sonnet BioTherapeutics Stock Forecast 2025
Based on our predictive models, Sonnet BioTherapeutics (SONN) is expected to trade between $0.00 and $4.90 throughout 2026. This would result in an average price of $0.28, potentially offering investors a -77.78% return from current levels.
Sonnet BioTherapeutics Holdings, Inc. Monthly Forecast 2025–2026
December 2025
According to our latest forecast models, Sonnet BioTherapeutics Holdings, Inc. (SONN) is positioned to show a strong performance in December 2025. The price is predicted to move between $0.00 and $4.26, settling at an average of $0.61. This could translate to a -51.59% loss.
January 2026
Based on current market signals, Sonnet BioTherapeutics Holdings, Inc. is projected to trend january 2026. We forecast a trading range from $0.00 to $4.63, with a likely average price of $0.44. Investors could expect a potential return of -65.08%.
February 2026
Our predictive algorithms indicate Sonnet BioTherapeutics Holdings, Inc. stock may see a shift in February 2026. The expected range spans $0.00–$4.44, with an average target of $0.43. This represents a cautious outlook and a possible loss of -65.87%.
March 2026
Analyzing established trends, Sonnet BioTherapeutics Holdings, Inc. looks set to move in March 2026. Projections place the stock between $0.00 and $4.90, averaging around $0.42. This suggests a -66.67% loss from current levels.
April 2026
Market indicators suggest Sonnet BioTherapeutics Holdings, Inc. could experience notable changes during April 2026. Prices could fluctuate within $0.00 to $4.56, with a midpoint forecast of $0.20. The stock might deliver a -84.13% loss.
May 2026
Forecasting for May 2026, models estimate that Sonnet BioTherapeutics Holdings, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $4.77, averaging $0.30. This signals a cautious trajectory with potential returns around -76.19%.
June 2026
According to our latest forecast models, Sonnet BioTherapeutics Holdings, Inc. (SONN) is positioned to show a strong performance in June 2026. The price is predicted to move between $0.00 and $4.63, settling at an average of $0.44. This could translate to a -65.08% loss.
July 2026
Based on current market signals, Sonnet BioTherapeutics Holdings, Inc. is projected to trend july 2026. We forecast a trading range from $0.00 to $4.38, with a likely average price of $0.32. Investors could expect a potential return of -74.60%.
August 2026
Our predictive algorithms indicate Sonnet BioTherapeutics Holdings, Inc. stock may see a shift in August 2026. The expected range spans $0.00–$4.48, with an average target of $0.29. This represents a cautious outlook and a possible loss of -76.98%.
September 2026
Analyzing established trends, Sonnet BioTherapeutics Holdings, Inc. looks set to move in September 2026. Projections place the stock between $0.00 and $4.42, averaging around $0.13. This suggests a -89.68% loss from current levels.
October 2026
Market indicators suggest Sonnet BioTherapeutics Holdings, Inc. could experience notable changes during October 2026. Prices could fluctuate within $0.00 to $4.21, with a midpoint forecast of $0.13. The stock might deliver a -89.68% loss.
November 2026
Forecasting for November 2026, models estimate that Sonnet BioTherapeutics Holdings, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $4.14, averaging $0.06. This signals a cautious trajectory with potential returns around -95.24%.
December 2026
According to our latest forecast models, Sonnet BioTherapeutics Holdings, Inc. (SONN) is positioned to show a strong performance in December 2026. The price is predicted to move between $0.00 and $3.87, settling at an average of $0.03. This could translate to a -97.62% loss.
SONN's history of dividends and stock splits also plays a role in long-term investor confidence.